{"id":"https://openalex.org/W2219358951","doi":null,"title":"Expression pattern of HLA class I antigens in renal cell carcinoma and primary cell line cultures: methodological implications for immunotherapy.","display_name":"Expression pattern of HLA class I antigens in renal cell carcinoma and primary cell line cultures: methodological implications for immunotherapy.","publication_year":2009,"publication_date":"2009-12-01","ids":{"openalex":"https://openalex.org/W2219358951","mag":"2219358951","pmid":"https://pubmed.ncbi.nlm.nih.gov/19946235"},"language":"en","primary_location":{"id":"pmid:19946235","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19946235","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Medical science monitor : international medical journal of experimental and clinical research","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5014172720","display_name":"Libor Han\u00e1k","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I21449261","display_name":"Masaryk University","ror":"https://ror.org/02j46qs45","country_code":"CZ","type":"education","lineage":["https://openalex.org/I21449261"]}],"countries":["CZ"],"is_corresponding":false,"raw_author_name":"Libor Hanak","raw_affiliation_strings":["University Cell Immunotherapy Center, Masaryk University, Brno, Czech Republic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Cell Immunotherapy Center, Masaryk University, Brno, Czech Republic","institution_ids":["https://openalex.org/I21449261"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090844895","display_name":"Ond\u0159ej Slab\u00fd","orcid":"https://orcid.org/0000-0002-8450-0584","observed_orcids":["https://orcid.org/0000-0002-8450-0584"]},"institutions":[{"id":"https://openalex.org/I21449261","display_name":"Masaryk University","ror":"https://ror.org/02j46qs45","country_code":"CZ","type":"education","lineage":["https://openalex.org/I21449261"]},{"id":"https://openalex.org/I4210115043","display_name":"Masaryk Memorial Cancer Institute","ror":"https://ror.org/0270ceh40","country_code":"CZ","type":"facility","lineage":["https://openalex.org/I4210115043"]}],"countries":["CZ"],"is_corresponding":false,"raw_author_name":"Ondrej Slaby","raw_affiliation_strings":["University Cell Immunotherapy Center, Masaryk University, Brno, Czech Republic and Department of Laboratory Medicine, Masaryk Memorial Cancer Institute, Brno, Czech Republic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Cell Immunotherapy Center, Masaryk University, Brno, Czech Republic and Department of Laboratory Medicine, Masaryk Memorial Cancer Institute, Brno, Czech Republic","institution_ids":["https://openalex.org/I21449261","https://openalex.org/I4210115043"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054620388","display_name":"L Lauerov\u00e1","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210115043","display_name":"Masaryk Memorial Cancer Institute","ror":"https://ror.org/0270ceh40","country_code":"CZ","type":"facility","lineage":["https://openalex.org/I4210115043"]}],"countries":["CZ"],"is_corresponding":false,"raw_author_name":"Ludmila Lauerova","raw_affiliation_strings":["Department of Oncological and Experimental Pathology, Masaryk Memorial Cancer Institute, Brno, Czech Republic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncological and Experimental Pathology, Masaryk Memorial Cancer Institute, Brno, Czech Republic","institution_ids":["https://openalex.org/I4210115043"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054763617","display_name":"Leo\u0161 K\u0159en","orcid":"https://orcid.org/0000-0002-9509-1552","observed_orcids":["https://orcid.org/0000-0002-9509-1552"]},"institutions":[{"id":"https://openalex.org/I4210102302","display_name":"University Hospital Brno","ror":"https://ror.org/00qq1fp34","country_code":"CZ","type":"healthcare","lineage":["https://openalex.org/I4210102302"]}],"countries":["CZ"],"is_corresponding":false,"raw_author_name":"Leos Kren","raw_affiliation_strings":["Institute of Pathology, University Hospital Brno, Brno, Czech Republic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Pathology, University Hospital Brno, Brno, Czech Republic","institution_ids":["https://openalex.org/I4210102302"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073500944","display_name":"Rudolf Nenutil","orcid":"https://orcid.org/0000-0003-0068-9760","observed_orcids":["https://orcid.org/0000-0003-0068-9760"]},"institutions":[{"id":"https://openalex.org/I4210115043","display_name":"Masaryk Memorial Cancer Institute","ror":"https://ror.org/0270ceh40","country_code":"CZ","type":"facility","lineage":["https://openalex.org/I4210115043"]}],"countries":["CZ"],"is_corresponding":false,"raw_author_name":"Rudolf Nenutil","raw_affiliation_strings":["Department of Oncological and Experimental Pathology, Masaryk Memorial Cancer Institute, Brno, Czech Republic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncological and Experimental Pathology, Masaryk Memorial Cancer Institute, Brno, Czech Republic","institution_ids":["https://openalex.org/I4210115043"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5034766695","display_name":"Jaroslav Mich\u00e1lek","orcid":"https://orcid.org/0000-0002-8719-5722","observed_orcids":["https://orcid.org/0000-0002-8719-5722"]},"institutions":[{"id":"https://openalex.org/I21449261","display_name":"Masaryk University","ror":"https://ror.org/02j46qs45","country_code":"CZ","type":"education","lineage":["https://openalex.org/I21449261"]}],"countries":["CZ"],"is_corresponding":false,"raw_author_name":"Jaroslav Michalek","raw_affiliation_strings":["University Cell Immunotherapy Center, Masaryk University, Brno, Czech Republic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Cell Immunotherapy Center, Masaryk University, Brno, Czech Republic","institution_ids":["https://openalex.org/I21449261"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.6957,"has_fulltext":false,"cited_by_count":22,"citation_normalized_percentile":{"value":0.71984661,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"15","issue":"12","first_page":"CR638","last_page":"43"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.45260000228881836,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.45260000228881836,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.19200000166893005,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.18979999423027039,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/renal-cell-carcinoma","display_name":"renal cell carcinoma","score":0.9909999966621399},{"id":"https://openalex.org/keywords/hla-class-i-antigens","display_name":"HLA class I antigens","score":0.9929999709129333},{"id":"https://openalex.org/keywords/hla-g","display_name":"HLA-G","score":0.9670000076293945},{"id":"https://openalex.org/keywords/hla-e","display_name":"HLA-E","score":1.0},{"id":"https://openalex.org/keywords/tumor-immune-evasion","display_name":"tumor immune evasion","score":0.6399999856948853},{"id":"https://openalex.org/keywords/explant-culture","display_name":"explant culture","score":0.8939999938011169},{"id":"https://openalex.org/keywords/chemoresistance","display_name":"chemoresistance","score":0.9300000071525574},{"id":"https://openalex.org/keywords/hla-abc","display_name":"HLA-ABC","score":0.7829999923706055}],"concepts":[{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.7112088203430176},{"id":"https://openalex.org/C188280979","wikidata":"https://www.wikidata.org/wiki/Q911125","display_name":"Human leukocyte antigen","level":3,"score":0.7047337293624878},{"id":"https://openalex.org/C2777472916","wikidata":"https://www.wikidata.org/wiki/Q1164529","display_name":"Renal cell carcinoma","level":2,"score":0.5950877070426941},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5231931209564209},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5162408351898193},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.4826400876045227},{"id":"https://openalex.org/C204232928","wikidata":"https://www.wikidata.org/wiki/Q899285","display_name":"Immunohistochemistry","level":2,"score":0.438925176858902},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3944280445575714},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3907117247581482},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.3817276656627655},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.37201493978500366},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.232961505651474},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000097625","descriptor_name":"HLA-E Antigens","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002292","descriptor_name":"Carcinoma, Renal Cell","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D002292","descriptor_name":"Carcinoma, Renal Cell","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006680","descriptor_name":"HLA Antigens","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007150","descriptor_name":"Immunohistochemistry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007680","descriptor_name":"Kidney Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D007680","descriptor_name":"Kidney Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015234","descriptor_name":"HLA-A Antigens","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015235","descriptor_name":"HLA-B Antigens","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015236","descriptor_name":"HLA-C Antigens","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015395","descriptor_name":"Histocompatibility Antigens Class I","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D018929","descriptor_name":"Cell Culture Techniques","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D059951","descriptor_name":"HLA-G Antigens","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:19946235","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19946235","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Medical science monitor : international medical journal of experimental and clinical research","raw_type":"Journal Article"},{"id":"mag:2219358951","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19946235","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2408894826","https://openalex.org/W2397811332","https://openalex.org/W1977255671","https://openalex.org/W1993215425","https://openalex.org/W1990119167","https://openalex.org/W7099432529","https://openalex.org/W2027061830","https://openalex.org/W2075674719","https://openalex.org/W2054929375","https://openalex.org/W2118124078"],"abstract_inverted_index":{"BACKGROUND:":[0],"Renal":[1,83],"cell":[2,11,56,61,105,176,198,224,233],"carcinomas":[3,234],"have":[4],"developed":[5],"various":[6],"strategies":[7],"to":[8,99,108],"escape":[9],"immune":[10],"recognition,":[12],"including":[13],"down-regulation":[14],"or":[15,180,213],"loss":[16],"of":[17,29,77,103,121,130,150,173,195,231],"classic":[18,41,140,184],"HLA":[19,31,44,65,204],"class":[20,32,45,66,205],"I":[21,33,46,67,206],"antigens":[22,34,47,68,136,145],"(A,":[23],"B,":[24,186],"C)":[25],"and":[26,42,53,74,113,119,134,143,159,162,187,209],"aberrant":[27],"expression":[28,208],"non-classic":[30,43,132],"(G,":[35],"E).":[36],"In":[37],"this":[38],"study":[39],"both":[40],"were":[48,69,115,146,155,168,191],"tested":[49],"in":[50,117,171,183],"tumor":[51,84,124],"specimens":[52,230],"established":[54,170],"primary":[55,104,197,223],"cultures":[57,107,167,226],"derived":[58,227],"from":[59,87,228],"renal":[60,153,175,232],"carcinoma":[62,177],"patients.":[63],"MATERIAL/METHODS:":[64],"evaluated":[70],"by":[71],"immunohistochemical":[72],"staining":[73,79,190],"the":[75,92,101,122,131,139,151,174,196],"intensity":[76],"cytoplasmic":[78],"was":[80,89,97,216],"measured":[81],"semiquantitatively.":[82],"tissue":[85],"obtained":[86],"nephrectomy":[88],"used":[90],"for":[91,239],"explant":[93],"culture.":[94],"MTT":[95],"assay":[96],"performed":[98],"test":[100],"chemoresistance":[102],"line":[106,166,199,225],"common":[109],"cytostatics.":[110],"RESULTS:":[111],"HLA-G":[112,133,163],"HLA-E":[114],"found":[116],"62%":[118],"100%":[120],"analyzed":[123],"samples,":[125],"respectively.":[126],"Markedly":[127],"higher":[128],"levels":[129],"-E":[135,160],"compared":[137],"with":[138],"HLA-A,":[141,156,185],"-B,":[142,157],"-C":[144],"observed.":[147],"The":[148],"cells":[149],"control":[152],"tissues":[154],"-C,":[158],"positive":[161],"negative.":[164],"Cell":[165],"successfully":[169],"85%":[172],"specimens.":[178],"No":[179,201],"minimal":[181],"changes":[182],"C":[188],"antigen":[189,207],"observed":[192],"during":[193],"cultivation":[194,245],"cultures.":[200],"correlation":[202],"between":[203],"chemoresistance,":[210],"histopathological":[211],"stage,":[212],"nuclear":[214],"grade":[215],"found.":[217],"CONCLUSIONS:":[218],"These":[219],"findings":[220],"suggest":[221],"that":[222],"surgical":[229],"are":[235],"a":[236],"feasible":[237],"model":[238],"immunotherapy":[240],"research":[241],"through":[242],"their":[243],"high":[244],"potential.":[246]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":3},{"year":2019,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}